ホーム
Event Top
Pitch Contest(
TOP > Pitch Contest > Finalist Details
FerroptoCure Inc.
Yuji Otsuki
CEO
Eliminating Hard‑to‑Treat Cancer by Breaking Its Antioxidant Shields
FerroptoCure is developing a first‑in‑class oral cancer drug that removes the shield protecting hard‑to‑treat cancers. By breaking cancer’s own defense system, FerroptoCure aims to turn today’s deadliest, drug‑resistant cancers into treatable diseases worldwide.
FerroptoCure is developing a first‑in‑class oral cancer drug that removes the shield protecting hard‑to‑treat cancers. By breaking cancer’s own defense system, FerroptoCure aims to turn today’s deadliest, drug‑resistant cancers into treatable diseases worldwide.